About StemCyte
StemCyte is a company based in Covina (United States) founded in 1997. StemCyte has raised $23.25 million across 6 funding rounds from investors including unknown. The company has 43 employees as of December 31, 2022. StemCyte operates in a competitive market with competitors including China Cord Blood, Generate, LaCell, Forever Labs and Provia Labs, among others.
- Headquarter Covina, United States
- Employees 43 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Stemcyte, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.25 M (USD)
in 6 rounds
-
Latest Funding Round
$2.5 M (USD), Debt – Conventional
Nov 22, 2010
- Investors
-
Employee Count
43
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of StemCyte
StemCyte has successfully raised a total of $23.25M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $2.5 million completed in November 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Debt – Conventional — $2.5M
-
First Round
First Round
(22 Mar 2002)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2010 | Amount | Debt – Conventional - StemCyte | Valuation |
investors |
|
| Oct, 2008 | Amount | Series B - StemCyte | Valuation |
investors |
|
| Aug, 2006 | Amount | Series B - StemCyte | Valuation |
investors |
|
Investors in StemCyte
StemCyte has secured backing from 1 investor. Prominent investors backing the company include unknown.
| Investor | Description | Founded Year | Domain | Location |
|---|
Investments & Acquisitions by StemCyte
Financial Statements - StemCyte
Stemcyte Comparisons
Competitors of StemCyte
StemCyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as China Cord Blood, Generate, LaCell, Forever Labs and Provia Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biobanking services for umbilical cord blood stem cells are provided.
|
|
| domain | founded_year | HQ Location |
Provider of services for the storage of stem cells
|
|
| domain | founded_year | HQ Location |
Stem Cell Production
|
|
| domain | founded_year | HQ Location |
Stem cells are stored and preserved for future therapeutic applications.
|
|
| domain | founded_year | HQ Location |
Stem cell biobanking and manufacturing from children's teeth are provided.
|
Latest news on Stemcyte
Frequently Asked Questions about StemCyte
StemCyte was founded in 1997 and raised its 1st funding round 5 years after it was founded.
StemCyte is headquartered in Covina, United States. It is registered at Covina, California, United States.
StemCyte is a funded company, having raised a total of $23.25M across 6 funding rounds to date. The company's 1st funding round was a Series B of $9.05M, raised on Mar 22, 2002.
As of Dec 31, 2022, the latest employee count at StemCyte is 43.
StemCyte was founded in 1997 and focuses on umbilical cord blood stem cell transplantation and therapeutic products. Cord blood products are delivered to transplant centers for treating blood cancers, immune disorders, and genetic conditions. Storage facilities are maintained in California and Taiwan, with operations spanning the United States, India, and Taiwan. Headquarters are located in Covina, California, supporting global access to these medical resources.
StemCyte's top competitors include Forever Labs, China Cord Blood and LaCell.
StemCyte has 1 investor. Key investors include unknown.